Nuveen’s Esperion Therapeutics ESPR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.9M Buy
3,613,709
+1,596
+0% +$5.05K ﹤0.01% 1562
2025
Q4
$13.4M Sell
3,612,113
-98,956
-3% -$320K ﹤0.01% 1383
2025
Q3
$9.83M Buy
3,711,069
+3,288,456
+778% +$6.36M ﹤0.01% 1567
2025
Q2
$416K Sell
422,613
-2,665,087
-86% -$2.67M ﹤0.01% 2941
2025
Q1
$4.45M Sell
3,087,700
-31,553
-1% -$58.1K ﹤0.01% 1982
2024
Q4
$6.86M Buy
3,119,253
+1,020,243
+49% +$2.38M ﹤0.01% 1819
2024
Q3
$3.46M Sell
2,099,010
-173,618
-8% -$351K ﹤0.01% 2162
2024
Q2
$5.05M Buy
+2,272,628
New +$5.35M ﹤0.01% 1950
2023
Q2
Sell
-792,772
Closed -$1.26M 3232
2023
Q1
$1.26M Sell
792,772
-226,424
-22% -$1.17M ﹤0.01% 2517
2022
Q4
$6.35M Buy
1,019,196
+717,837
+238% +$5.13M ﹤0.01% 1781
2022
Q3
$2.02M Buy
301,359
+106,392
+55% +$731K ﹤0.01% 2400
2022
Q2
$1.24M Sell
194,967
-145,932
-43% -$827K ﹤0.01% 2692
2022
Q1
$1.89M Buy
340,899
+261,772
+331% +$1.12M ﹤0.01% 2531
2021
Q4
$395K Sell
79,127
-18,987
-19% -$152K ﹤0.01% 3126
2021
Q3
$1.23M Sell
98,114
-67,884
-41% -$988K ﹤0.01% 2910
2021
Q2
$3.51M Sell
165,998
-48,136
-22% -$1.16M ﹤0.01% 2425
2021
Q1
$6.01M Buy
214,134
+95,919
+81% +$2.83M ﹤0.01% 2086
2020
Q4
$3.07M Sell
118,215
-8,144
-6% -$244K ﹤0.01% 2293
2020
Q3
$4.7M Sell
126,359
-38,767
-23% -$1.54M ﹤0.01% 1951
2020
Q2
$8.47M Sell
165,126
-19,221
-10% -$804K ﹤0.01% 1595
2020
Q1
$5.81M Buy
184,347
+20,371
+12% +$1.08M ﹤0.01% 1621
2019
Q4
$9.78M Sell
163,976
-125,700
-43% -$5.65M ﹤0.01% 1601
2019
Q3
$10.6M Sell
289,676
-95,068
-25% -$3.77M ﹤0.01% 1534
2019
Q2
$17.9M Buy
+384,744
New +$18.1M 0.01% 1222

Other funds holding ESPR